BioLineRX Receives $8M Investment

BioLineRX Receives $8M InvestmentIsraeli drug development company BioLineRX has announced that it will receive an $8 million investment from OrbiMed Israel Partners LP. BioLineRX says that it will use the funds to continue the development of its clinical and pre-clinical state therapeutic assets.